# Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System
Canonical URL: https://biopharmsignal.com/news/AORT/artivion-announces-u-s-fda-approval-of-the-nexusr-aortic-arch-system
Ticker: AORT
Company: Artivion
Source: Artivion
Published: 2026-04-07 11:00 EST
Original Source URL: https://investors.artivion.com
## Summary

Endospan's NEXUS branched endovascular stent graft system shown to effectively treat aortic arch disease, including chronic aortic dissections ATLANTA, April 7, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today

## Article Body
Endospan's NEXUS branched endovascular stent graft system shown to effectively treat aortic arch disease, including chronic aortic dissections ATLANTA, April 7, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today
## Recent Company News
- 2026-05-18 11:00 EST — [Artivion Completes Acquisition of Endospan Ltd.](https://biopharmsignal.com/news/AORT/artivion-completes-acquisition-of-endospan-ltd) — Source: Artivion
- 2026-05-07 20:05 EST — [Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan](https://biopharmsignal.com/news/AORT/artivion-reports-first-quarter-2026-financial-results-and-announces-exercise-of-option-to-acquire-endospan) — Source: Artivion
- 2026-04-23 20:15 EST — [Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results](https://biopharmsignal.com/news/AORT/artivion-announces-release-date-and-teleconference-call-details-for-first-quarter-2026-financial-results) — Source: Artivion
- 2026-04-07 11:00 EST — [Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System](https://biopharmsignal.com/news/AORT/artivion-announces-u-s-fda-approval-of-the-nexusr-aortic-arch-system) — Source: Artivion
- 2026-03-03 21:10 EST — [Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference](https://biopharmsignal.com/news/AORT/artivion-to-participate-in-the-oppenheimer-36th-annual-healthcare-medtech-and-services-conference) — Source: Artivion
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)